ClinicalTrials.gg
Not yet recruitingNCT07634887Updated Jun 9, 2026

Gastrointestinal Health Survey of Dalian College Students

An observational study in Gastrointestinal Symptoms, sponsored by DiproBio (Shanghai) Co., Ltd.. Not yet recruiting. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-06-09.

Sponsored by DiproBio (Shanghai) Co., Ltd. · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,020
Ages
18 Years to 25 Years
Sex
All
01

Study summary

This is a cross-sectional study aimed to investigate the current status of gastrointestinal health among full-time undergraduate students aged 18-25 years in Dalian, and to clarify the influences of factors such as diet, sleep, psychological mood, and antibiotic use on gastrointestinal symptoms, as well as gender differences. The study plans to enroll 1020 eligible college students and collect information including demographics, gastrointestinal symptoms in the past month, lifestyle, and medication use. Statistical analyses will be performed using the chi-square test, Mann-Whitney U test, Spearman correlation analysis, and multivariate logistic regression. The primary objective is to assess the prevalence and distribution characteristics of gastrointestinal discomfort among college students; the secondary objectives are to identify independent risk factors and analyze gender differences. The results of this study will provide data support for colleges and universities to carry out gastrointestinal health education, schedule and dietary interventions, and rational medication guidance, as well as evidence-based basis for improving digestive health in young populations.

Read the detailed description

Against the backdrop of a clear trend toward younger-onset digestive health problems, college students, after leaving family care and with insufficient self-management skills as well as increasing academic and social pressure, commonly engage in irregular eating habits, staying up late, emotional fluctuations, and inappropriate medication use. These behaviors contribute to a high prevalence of gastrointestinal discomfort, which may increase the risk of chronic gastrointestinal diseases in the long run. Gastrointestinal health among college students directly affects their academic performance, quality of life, and physical and mental health development. Currently, large-scale, multi-factor surveys on gastrointestinal health among college students in Northeast China remain scarce, and modifiable risk factors are not yet clearly defined. This study focuses on university students in Dalian, conducting a cross-sectional epidemiological survey to clarify the current status and key influencing factors, and to provide scientific support for campus health management and the development of health promotion strategies.

Numerous epidemiological surveys at home and abroad have shown that digestive diseases rank among the leading causes of hospitalization among college students, with a persistently high detection rate of gastrointestinal discomfort. Abnormal dietary patterns, disrupted sleep rhythms, accumulated psychological stress, and inappropriate antibiotic use can lead to symptoms such as abdominal pain, bloating, acid reflux, and heartburn by disrupting the gut microbiota, affecting gut-brain axis signaling, and inducing low-grade inflammation.

The gut microbiota is a core component in maintaining gastrointestinal function. Diet, sleep, emotions, and medication use can significantly alter the structure and diversity of the microbiota, thereby affecting intestinal barrier function, motility, and visceral sensation. Existing studies have indicated that skipping breakfast, binge eating, insufficient sleep, emotional distress, and antibiotic overuse are important risk factors for gastrointestinal discomfort in young populations. However, most previous studies have been limited by small sample sizes, insufficient regional representativeness, and lack of systematic analysis of gender differences and multi-factor interactions, leaving a notable gap in high-quality cross-sectional data for college students in Dalian.

Building on existing research, this study expands the sample size, uses standardized questionnaires and rigorous statistical methods to systematically analyze modifiable risk factors, fill the gap in regional data, and provide a basis for the development of targeted health interventions.

02

Conditions studied

  • Gastrointestinal Symptoms
03

In context

Lead sponsor

DiproBio (Shanghai) Co., Ltd. is the lead sponsor of 5 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Full-time undergraduate students aged 18-25 years enrolled in universities in Dalian, China, with no severe gastrointestinal diseases, no major surgery or gastrointestinal treatment in the recent past, and no long-term use of medications affecting gastrointestinal function.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged between 18 and 25 years, and currently enrolled as a full-time undergraduate student at a university in Dalian, China.
  2. Voluntarily participates in the study and provides online .
  3. Able to independently complete and submit the entire questionnaire.

Exclusion criteria

Exclusion Criteria:

  1. Individuals with severe organic gastrointestinal diseases or those who have undergone gastrointestinal surgery recently.
  2. Individuals on long-term medication that affects gastrointestinal function.
  3. Questionnaires that are incomplete, contain logical contradictions, or are submitted more than once by the same participant.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,020 participants (estimated)
Patient registry
No

Groups and cohorts

  • Full-Time Undergraduate Students in Dalian

    Full-time undergraduate students aged 18-25 years enrolled in universities in Dalian, China.

    Other: Self-Administered Questionnaire Survey

Interventions

  • OtherSelf-Administered Questionnaire Survey

    This is an observational cross-sectional study with no interventional measures. The only activity is completion of a self-administered questionnaire to collect data on gastrointestinal health and related factors. No drugs, devices, or behavioral interventions are provided to participants.

06

What researchers measure

Primary outcomes

  1. Prevalence of Gastrointestinal Symptoms Among College Students

    Time frame: Baseline (single time point, cross-sectional data collection)

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2026; primary completion for Apr 2027, 10 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 18, 2026
First posted
Jun 9, 2026
StartEst.
May 15, 2026
Primary completionEst.
Apr 14, 2027
CompletionEst.
May 14, 2027
Last update
Jun 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07634887
Responsible party
Sponsor
First posted
Jun 9, 2026
Start date
May 15, 2026 (estimated)
Primary completion
Apr 14, 2027 (estimated)
Completion
May 14, 2027 (estimated)
Last update
Jun 9, 2026

Study contacts

Huajun Li
Contact
lhjcmu@hotmail.com
86-411 8611 0282
Huajun Li
principal investigator · Dalian Medical University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion